Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
Growth arrest induced by serum depletion and/or treatment with mevinolin (an inhibitor of mevalonate synthesis) in the human breast cancer cell line Hs578T was overcome by exogenous mevalonate, indicating that some product or metabolite of mevalonate may be involved in the mediation of serum-regulated growth of these cells. In the search for such compounds we first tested a variety of known end products of mevalonate with respect to their ability to counteract the inhibition of DNA synthesis caused by serum-free medium and mevinolin. Thereby high doses (10 micrograms/ml) of dolichol-20 were found to cause a partial counteraction. After straight-phase HPLC purification of endogenous lipids, isolated from 3H- or 14C-mevalonate-labelled Hs578T cultures, we found that non-sterol lipids co-eluting with dolichols efficiently induced DNA synthesis. After further purification with reverse-phase HPLC it was confirmed that virtually all of this effect was achieved by compounds(s) (seen as a single UV and radioactive peak) co-eluting with dolichol-20. Nanogram doses, at most, of this (these) compound(s) elicited a substantial stimulation of DNA synthesis. The lipid(s) also counteracted the inhibition by mevinolin of N-linked glycosylation, indicating that it (they) also interfere(s) with this processing. Since treatment with tunicamycin (an inhibitor of N-linked glycosylation) abolished this growth-stimulative effect, N-linked glycosylation seems to be a necessary event in the processes leading to lipid-induced initiation of DNA synthesis.
Wejde
J
J
Department of Tumor Pathology, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden.
Carlberg
M
M
Hjertman
M
M
Larsson
O
O
D001769:Blood; D001943:Breast Neoplasms / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D003470:Culture Media; D004247:DNA / Q000096:biosynthesis*; D004286:Dolichols / Q000494:pharmacology; D006031:Glycosylation; D006801:Humans; D008148:Lovastatin / Q000494:pharmacology; D008798:Mevalonic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014415:Tunicamycin / Q000494:pharmacology
D003470:Culture Media; D004286:Dolichols; D014415:Tunicamycin; D004247:DNA; D008148:Lovastatin; D008798:Mevalonic Acid